CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

AstraZeneca opens new R&D centre in Cambridge, US

Positive
AI Analysis

Summary

AstraZeneca has opened a new global strategic R&D facility in Massachusetts as part of an investment exceeding $1 billion in the state.

Importance:3/10
Sentiment:
0.40
R&D facilitycapital investmentMassachusettsfacility expansion
Related Companies

Read the original article

Published by Pharmaceutical Technology on October 6, 2026 7:54 AM

Read Original